Z-0372-2023 Class II Terminated

Recalled by Medacta Usa Inc — Memphis, TN

FDA device recall Z-0372-2023 was initiated by Medacta Usa Inc on October 27, 2022 and is designated Class II. Reason for recall: A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target f… The recall status is terminated (terminated October 23, 2023). Affected quantity: 14 units.

Recall Details

Product Type
Devices
Report Date
December 14, 2022
Initiation Date
October 27, 2022
Termination Date
October 23, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14 units

Product Description

NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a reverse shoulder arthroplasty on the glenoid

Reason for Recall

A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid bone and relevant patient conditions are suitable before proceeding.

Distribution Pattern

AL, FL, NH, CO, IL, SC, AR

Code Information

Document Reference Code 99.81NEXTAR.12US (for US market only), Revision Numbers: Rev.02 and previous